Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial

PaperCitations, authors & open-access status

Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 92 citations, 2019 year and closed oa status.

92
Citations
2019
Year
closed
OA Status

Related on ScholarIQ

Daichi Fujimoto
Author
Lung Cancer
Journal
Cancer Immunotherapy and Biomarkers
Topic
Cancer Immunotherapy and Biomarkers
Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account